Daniela Stadler - Publications

Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniques.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: March 04, 2024

SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.

Journal: Microbiology spectrum

Published: May 18, 2023

Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene Expression.

Journal: mBio

Published: May 08, 2023

Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells.

Journal: Journal of pharmaceutical sciences

Published: December 07, 2021

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.

Journal: Computational and structural biotechnology journal

Published: September 25, 2021

T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice.

Journal: Journal of hepatology

Published: August 20, 2020

Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesicles.

Journal: Journal of extracellular vesicles

Published: February 16, 2020

Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.

Journal: EMBO reports

Published: October 30, 2019

Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected Hepatocytes.

Journal: The Journal of infectious diseases

Published: October 21, 2018

PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice.

Journal: Antiviral research

Published: July 27, 2018

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.

Journal: Journal of hepatology

Published: February 12, 2018

Analyses of HBV cccDNA Quantification and Modification.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 16, 2016